RetinalGenix Technologies (RTGN) Receivables - Other (2020 - 2023)

RetinalGenix Technologies has disclosed Receivables - Other across 4 years of filings, most recently posting $622806.0 for Q1 2023.

• Receivables - Other for Q1 2023 came in at $622806.0, up 76.22% year-over-year; the trailing twelve-month figure through Mar 2023 was $622806.0 (up 76.22% YoY), and the FY2022 annual result was $427933.0, up 199.84% from the prior year.
• Receivables - Other came in at $622806.0 for Q1 2023 at RetinalGenix Technologies, up from $427933.0 in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $622806.0 in Q1 2023 to a low of -$15069.0 in Q4 2020.
• The 4-year median for Receivables - Other is $284415.0 (2022), against an average of $309165.5.
• Across the five-year window, Receivables - Other soared 1047.12% in 2021 and soared 76.22% in 2023, its largest moves.
• RetinalGenix Technologies' Receivables - Other stood at -$15069.0 in 2020, then jumped by 1047.12% to $142721.0 in 2021, then jumped by 199.84% to $427933.0 in 2022, then surged by 45.54% to $622806.0 in 2023.
• The last three Receivables - Other figures came in at $622806.0 (Q1 2023), $427933.0 (Q4 2022), and $561870.0 (Q3 2022), per Business Quant data.